COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1114: Articles 11131-11140  | Next

SARS-CoV-2 ORF8 encoded protein contains a histone mimic, disrupts chromatin regulation, and enhances replication
Kee, J., Thudium, S., Renner, D., Glastad, K., Palozola, K., Zhang, Z., Li, Y., Cesare, J., Lan, Y., Truitt, R., Cardenas-Diaz, F. L., Kotton, D. N., Alysandratos, K. D., Zhang, X., Xie, X., Shi, P.-Y., Yang, W., Morrisey, E., Garcia, B. A., Berger, S. L., Weiss, S. R., Korb, E.
10.1101/2021.11.10.468057 — Posted: 2021-11-11 Discussion: Onsite
SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua, Florida
Rife Magalis, B., Rich, S., Tagliamonte, M. S., Mavian, C., Cash, M. N., Riva, A., Marini, S., Moraga Amador, D., Zhang, Y., Shapiro, J., Horine, A., Starostik, P., Pieretti, M., Vega, S., Lacombe, A. P., Salinas, J., STEVENSON, M., Myers, P., Morris, J. G., Lauzardo, M., Prosperi, M., Salemi, M.
10.1101/2021.11.10.21266134 — Posted: 2021-11-11
Frontline Healthcare workers suffering from psychosomatic disorders during COVID-19 (a pandemic): A Systematic review
Joshi, R., Agarwal, N. B., Bhurani, D., Khan, M. A.
10.1101/2021.11.09.21266105 — Posted: 2021-11-11
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
Lin, S., Kennedy, N. A., Saifuddin, A., Munoz Sandoval, D., Reynolds, C. J., Seoane, R. C., Kottoor, S. H., Pieper, F. P., Lin, K.-M., Butler, D. K., Chanchlani, N., Nice, R., Chee, D., Bewshea, C., Janjua, M., McDonald, T. J., Sebastian, S., Alexander, J. L., Constable, L., Lee, J. C., Murray, C. D., Hart, A. L., Irving, P. M., Jones, G.-R., Kok, K. B., Lamb, C. A., Lees, C. W., Altmann, D. M., Boyton, R. J., Goodhand, J. R., Powell, N., Ahmad, T., Contributors to the CLARITY IBD study
10.1101/2021.11.10.21266168 — Posted: 2021-11-11
Disparities in COVID-19 Fatalities among Working Californians
Cummings, K. J., Beckman, J., Frederick, M., Harrison, R., Nguyen, A., Snyder, R., Chan, E., Gibb, K., Rodriguez, A., Wong, J., Murray, E. L., Jain, S., Vergara, X.
10.1101/2021.11.10.21266195 — Posted: 2021-11-11 Discussion: Onsite | Offsite
The role of antiviral treatment in curbing the COVID-19 pandemic: a modeling study.
Matrajt, L., Brown, E. R., Dimitrov, D., Janes, H.
10.1101/2021.11.10.21266139 — Posted: 2021-11-11
A prototype vaccination model for endemic Covid-19 under waning immunity and imperfect vaccine take-up
Dagpunar, J. S., Wu, C.
10.1101/2021.11.06.21266002 — Posted: 2021-11-11 Discussion: Onsite
COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection
Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., Al-Delfi, Z., Abayasingam, A., Agapiou, D., Ospina Stella, A., Aggarwal, A., Gummow, J., Ferguson, C., O'Connor, S., McCartney, E. M., Lynn, D. J., Maddern, G., Gowans, E. J., Reddi, B. A., Shaw, D., Kok-Lim, C., Turville, S. G., Beard, M. R., Weiskopf, D., Sette, A., Bull, R. A., Barry, S. C., Grubor-Bauk, B.
10.1101/2021.11.08.21266035 — Posted: 2021-11-11
The β-NGF/TrkA signalling pathway is associated with the production of anti- nucleoprotein IgG in convalescent COVID-19
Usai, C., Gibbons, J. M., Pade, C., Li, W., McKnight, A., Kennedy, P. T. F., Gill, U. S.
10.1101/2021.11.11.21266223 — Posted: 2021-11-11
Mapping the human genetic architecture of COVID-19: an update
The COVID-19 Host Genetics Initiative, , Ganna, A.
10.1101/2021.11.08.21265944 — Posted: 2021-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).